SCM
IMNM icon

Sterling Capital Management’s Immunome IMNM Stock Holding History

Sterling Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5K Buy
663
+51
+8% +$1.14K ﹤0.01% 2179
2025
Q4 		$13.1K Buy
612
+425
+227% +$7.46K ﹤0.01% 2471
2025
Q3 		$2.19K Buy
187
+7
+4% +$70 ﹤0.01% 2961
2025
Q2 		$1.67K Buy
180
+106
+143% +$869 ﹤0.01% 2963
2025
Q1 		$498 Buy
74
+21
+40% +$201 ﹤0.01% 2957
2024
Q4 		$563 Hold
53
– – ﹤0.01% 3019
2024
Q3 		$775 Buy
+53
New +$753 ﹤0.01% 2670

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Sterling Capital Management's IMNM Position: Q1 2026 in Review

Sterling Capital Management increased its Immunome (IMNM) stake by 8.3% in Q1 2026, buying an estimated $1.14K and bringing the position to 663 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Sterling Capital Management first reported a position in IMNM in Q3 2024 and has held it in 7 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Sterling Capital Management held 663 shares of Immunome worth $14.5K as of Q1 2026.
  • Sterling Capital Management bought 51 Immunome shares in Q1 2026, an estimated $1.14K.
  • Immunome made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2179 holding.
  • Sterling Capital Management first reported a position in Immunome in Q3 2024 and has held it in 7 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.